Patients should inspect the medication before each use, looking for any signs of precipitation, cloudiness, or color changes
The possibility of a drug that could help both metabolic and brain health is exciting, but as with all promising treatments, the whole story is more complicated
Jennifer Manne-Goehler an obesity specialist with Mass General Brigham and consultant to the World Health Organization is concerned that people will access them and medicate themselves to meet a thinner ideal
Blue Zones Project by Healthways
E.FarzanehM
GLP-1 drugs can do a lot more than treat obesity and diabetes, with a growing list of indications for conditions including heart disease, obstructive sleep apnea, kidney disease, and advanced liver disease